Current recommendations are to treat ≤ 4 metastatic lesions with stereotactic or other focal radiation interventions and to treat> 4 lesions with whole-brain radiation therapy (1, 2); however, new data may support stereotactic surgery for up to 10 metastatic lesions (3, 4).